
Predian in the complex treatment of patients with diabetes mellitus
Author(s) -
I. V. Grigorieva
Publication year - 1988
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99687
Subject(s) - diabetes mellitus , sulfonamide , medicine , coagulation , intensive care medicine , endocrinology , chemistry , stereochemistry
The aim of this work was to study the effectiveness of predian (sulfonamide developed at the Research Institute Servier, France) as a sugar-lowering agent, as well as its effect on the coagulation and antiplatelet systems of diabetic patients.